Company Filing History:
2 out of 36 
1 out of 2 
1 out of 2,943 
Years Active: 1998-2007
Title: **The Innovations of Sean Evans in Allergy Treatment**
Introduction
Sean Evans, an accomplished inventor based in Acton, MA, is recognized for his significant contributions to the field of allergy treatment. With a total of four patents to his name, his innovative work centers around the development of therapeutic solutions targeting house dust mite allergies. Evans’ inventions promise to improve the quality of life for many individuals suffering from these common allergens.
Latest Patents
One of Sean Evans' groundbreaking patents involves T cell epitopes of the major allergens from dermatophagoides, specifically house dust mites. This invention provides isolated peptides from the major protein allergens of the genus Dermatophagoides. The peptides in this invention include at least one, or preferably two, T cell epitopes of protein allergens such as Der p I, Der p II, Der f I, or Der f II. Additionally, the patent pertains to modified peptides with similar or enhanced therapeutic properties while reducing adverse side effects. It also offers nucleic acid sequences coding for the peptides and outlines methods for diagnosing and treating sensitivity to house dust mites using these innovative compositions.
Career Highlights
Throughout his career, Sean Evans has made substantial contributions to pharmaceutical research and development. He has worked at esteemed organizations like Immunologic Pharmaceutical Corporation, where he applied his inventive skills to the advancement of allergy treatments. His career is marked by a dedication to enhancing therapeutic outcomes for patients suffering from allergic responses.
Collaborations
Evans has collaborated with notable colleagues in the field, including Richard D. Garman and Julia L. Greenstein. Their teamwork on various projects has further propelled the advancement of knowledge and technology in allergy treatments, significantly contributing to the scientific community.
Conclusion
Sean Evans exemplifies innovation in the realm of allergy treatment, demonstrated through his patented inventions that target house dust mite allergens. His work not only holds promise for improved therapeutic methods but also reflects his commitment to addressing pressing health issues. As he continues to develop solutions for allergy sufferers, the impact of his contributions will likely be felt for years to come.